These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25984868)

  • 1. Summaries for Patients. A value framework for cancer screening.
    Ann Intern Med; 2015 May; 162(10):. PubMed ID: 25984868
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries for Patients. Screening for cancer.
    Ann Intern Med; 2015 May; 162(10):. PubMed ID: 25984869
    [No Abstract]   [Full Text] [Related]  

  • 3. A value framework for cancer screening: advice for high-value care from the American College of Physicians.
    Harris RP; Wilt TJ; Qaseem A;
    Ann Intern Med; 2015 May; 162(10):712-7. PubMed ID: 25984846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cancer: advice for high-value care from the American College of Physicians.
    Wilt TJ; Harris RP; Qaseem A;
    Ann Intern Med; 2015 May; 162(10):718-25. PubMed ID: 25984847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles of Cancer Screening.
    Pinsky PF
    Surg Clin North Am; 2015 Oct; 95(5):953-66. PubMed ID: 26315516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A physician not doing too much is favorable for both the patient and the economy].
    Nilsson G
    Lakartidningen; 2013 Sep 25-Oct 8; 110(39-40):1720-1. PubMed ID: 24245425
    [No Abstract]   [Full Text] [Related]  

  • 7. Lung cancer screening: an update, discussion, and look ahead.
    Mazzone PJ
    Curr Oncol Rep; 2010 Jul; 12(4):226-34. PubMed ID: 20446065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision-making methodology for oral mucosal screening.
    Huff KD; Huff MS
    Dent Today; 2010 May; 29(5):68-71; quiz 71. PubMed ID: 20506912
    [No Abstract]   [Full Text] [Related]  

  • 9. Risks of PSA screening now better understood.
    Peres J
    J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
    [No Abstract]   [Full Text] [Related]  

  • 10. A framework provided an outline toward the proper evaluation of potential screening strategies.
    Adriaensen WJ; Matheï C; Buntinx FJ; Arbyn M
    J Clin Epidemiol; 2013 Jun; 66(6):639-47. PubMed ID: 23395357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comments and response on the USPSTF recommendation on screening for breast cancer.
    Begg CB
    Ann Intern Med; 2010 Apr; 152(8):540-1; author reply 543-4. PubMed ID: 20157101
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of anal cancer screening in HIV-positive women.
    Lazenby GB; Unal ER; Andrews AL; Simpson K
    J Low Genit Tract Dis; 2012 Jul; 16(3):275-80. PubMed ID: 22227844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Too Much Medicine: Time to Stop Indiscriminate Cancer Screening.
    Ng RC
    Ann Acad Med Singap; 2015 Jun; 44(6):194-6. PubMed ID: 26292946
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung cancer screening: examining the issues.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS1-6. PubMed ID: 22614958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine.
    Shapiro SD
    PLoS Med; 2017 Feb; 14(2):e1002226. PubMed ID: 28170392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of online direct-to-consumer tumor markers for cancer screening.
    Lovett KM; Liang BA; Mackey TK
    J Clin Oncol; 2012 May; 30(13):1411-4. PubMed ID: 22355060
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic analysis of active surveillance for localized prostate cancer.
    Kim S; Dall'Era MA; Evans CP
    Curr Opin Urol; 2012 May; 22(3):247-53. PubMed ID: 22388666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening in liver disease: report of an AASLD clinical workshop.
    Adams PC; Arthur MJ; Boyer TD; DeLeve LD; Di Bisceglie AM; Hall M; Levin TR; Provenzale D; Seeff L
    Hepatology; 2004 May; 39(5):1204-12. PubMed ID: 15122748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.